Cassava Sciences
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $2,348 | $0 |
Gross Profit | -300 | -311 | 1,992 | -392 |
EBITDA | -66,902 | -19,623 | -22,433 | -27,879 |
EBIT | -67,202 | -19,934 | -22,789 | -28,271 |
Net Income | 6,155 | 25,043 | -20,919 | -25,651 |
Net Change In Cash | 0 | 0 | 2,348 | 0 |
Free Cash Flow | -18,270 | -19,127 | -22,357 | -26,552 |
Cash | 207,291 | 124,169 | 121,136 | 142,350 |
Basic Shares | 46,202 | 44,102 | 42,188 | 42,002 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $-1 | $0 | $0 |
Gross Profit | -89,423 | -1 | -534 | -346 |
EBITDA | -104,427 | -78,719 | -32,334 | -7,138 |
EBIT | -105,957 | -80,020 | -32,868 | -7,160 |
Net Income | -97,217 | -72,472 | -31,802 | -5,854 |
Net Change In Cash | 0 | -1 | 0 | 0 |
Cost of Revenue | 139,931 | 70,425 | ||
Free Cash Flow | -82,439 | -80,226 | -52,410 | -5,382 |
Cash | 121,136 | 201,015 | 233,437 | 93,506 |
Basic Shares | 41,932 | 40,202 | 39,405 | 26,105 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | $0.13 |
2024-03-31 | $0.58 |
2023-12-31 | -$0.50 |
2023-09-30 | -$0.61 |
